Cardiome Pharma Corp. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cardiome Pharma Corp. with three other
companies in this sector in Canada:
sales of 42.86 million Canadian Dollars [US$33.65 million]
of which 100%
was Therapeutic Peptides),
Nuvo Pharmaceuticals Inc
(17.52 million Canadian Dollars [US$13.75 million]
(20.44 million Canadian Dollars [US$16.04 million]
Cardiome Pharma Corp. reported sales of C$31.09 million (US$24.40 million)
December of 2017.
decrease of 6.8%
versus 2016, when the company's sales were C$33.37 million.